(Q43273407)

English

Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma

scientific article published on 21 September 2009

Statements

Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma (English)
Jorge Enrique Romaguera
Maria Alma Rodriguez
Felipe Samaniego
Peter McLaughlin
Frederick Hagemeister
Amanda Copeland
Barry I Samuels
Evelyne M Loyer

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit